Table 3.
Etiologies of heart failure and baseline medications prescribed in study patients
| Characteristic | Values |
| Etiologies of heart failure, n (%) | |
| Ischemic heart disease | 13 (4.36) |
| Hypertensive heart disease | 150 (50.34) |
| Peripartum cardiomyopathy | 32 (10.74) |
| Restrictive cardiomyopathy | 17 (5.70) |
| Valvular heart disease | 20 (6.71) |
| Myocarditis‡ | 4 (1.34) |
| Cardiothyreosis | 3 (1.01) |
| Idiopathic dilated cardiomyopathy | 59 (19.80) |
| Medications, n (%) | |
| ACEI/ARBs | 295 (98.99) |
| Beta-blockers | 56 (18.79) |
| Aldosterone receptor antagonists | 205 (68.79) |
| Loop diuretics* | 290 (97.32) |
| Thiazide | 41 (13.76) |
| Calcium channel blockers | 15 (5.03) |
| Nitrates* | 176 (59.06) |
| Amiodarone | 33 (11.07) |
| Digoxin | 88 (29.53) |
| Vitamin K antagonists | 04 (1.34) |
| Antiplatelet | 193 (64.77) |
| Statins | 10 (3.36) |
| Iron supplementation | 65 (21.81) |
‡
Including 3 cases of HIV-related and one case of influenza virus, ACEI/ARB: Angiotensin-converting enzyme-inhibitors/Angiotensin receptor blockers
*
Loop diuretics and nitrates were only used until complete relief of congestive signs/symptoms.